Patents by Inventor Peter Josef Flor

Peter Josef Flor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Organic Compounds
    Publication number: 20080242698
    Abstract: The invention relates to novel diamines of the formula in which all variables are as defined in the specification, in free base form or in acid addition salt form, to their preparation, to their use as medicaments and to medicaments comprising them.
    Type: Application
    Filed: August 29, 2006
    Publication date: October 2, 2008
    Inventors: Peter Josef Flor, Andreas Marzinzik, Joachim Nozulak, Silvio Ofner, Bernard Lucien Roy, Carsten Spanka
  • Human metabotropic glutamate receptor subtype mGluR7b
    Patent number: 7253257
    Abstract: The invention provides purified human metabotropic glutamate receptors, compositions comprising such receptors, and nucleic acids that encode such receptors.
    Type: Grant
    Filed: December 30, 2002
    Date of Patent: August 7, 2007
    Assignee: Novartis Corporation
    Inventors: Peter Josef Flor, Rainer Kuhn, Kristin Lindauer, Irene Püttner, Thomas Knöpfel
  • Human metabotropic glutamate receptor subtype mGluR7b
    Publication number: 20030113868
    Abstract: The invention provides purified human metabotropic glutamate receptors, compositions comprising such receptors, and nucleic acids that encode such receptors.
    Type: Application
    Filed: December 30, 2002
    Publication date: June 19, 2003
    Inventors: Peter Josef Flor, Rainer Kuhn, Kristin Lindauer, Irene Puttner, Thomas Knopfel
  • Human metabotropic glutamate receptor 7 subtypes
    Patent number: 6515107
    Abstract: The present invention relates to human metabotropic glutamate receptor (hmGluR) proteins, isolated nucleic acids coding therefor, host cells producing the proteins of the invention, methods for the preparation of such proteins, nucleic acids and host cells, and uses thereof.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: February 4, 2003
    Assignee: Novartis Corporation
    Inventors: Peter Josef Flor, Rainer Kuhn, Kristin Lindauer, Irene Püttner, Thomas Knöpfel
  • Human metabotropic glutamate receptor 7 subtypes
    Publication number: 20020127638
    Abstract: The present invention relates to human metabotropic glutamate receptor (hmGluR) proteins, isolated nucleic acids coding therefor, host cells producing the proteins of the invention, methods for the preparation of such proteins, nucleic acids and host cells, and uses thereof.
    Type: Application
    Filed: March 26, 2001
    Publication date: September 12, 2002
    Inventors: Peter Josef Flor, Rainer Kuhn, Kristin Lindauer, Irene Puttner, Thomas Knopfel
  • MGluR5 antagonists for the treatment of pain and anxiety
    Publication number: 20010056084
    Abstract: The invention provides the use of selective mGluR5 antagonists for the treatment of pain and anxiety, and the use of mGluR antagonists for the treatment of pain, whereby analgesic effect is achieved by interaction of said antagonists primarily or predominantly at peripheral mGluR receptors.
    Type: Application
    Filed: March 29, 2001
    Publication date: December 27, 2001
    Inventors: Hans Allgeier, Nicholas David Cosford, Peter Josef Flor, Fabrizio Gasparini, Conrad Gentsch, Stephen D. Hess, Edwin Carl Johnson, Rainer Kuhn, Mark Tricklebank, Laszlo Urban, Mark Andrew Varney, Gonul Velicelebi, Katharine Walker
  • Human metabotropic glutamate receptor subtypes (hmR4, hmR6, hmR7) and related DNA compounds
    Patent number: 6228610
    Abstract: The present invention relates to human metabotropic glutamate receptor (hmGluR) proteins, isolated nucleic acids coding therefor, host cells producing the proteins of the invention, methods for the preparation of such proteins, nucleic acids and host cells, and uses thereof.
    Type: Grant
    Filed: March 19, 1996
    Date of Patent: May 8, 2001
    Assignee: Novartis Corporation
    Inventors: Peter Josef Flor, Rainer Kuhn, Kristin Lindauer, Irene Püttner, Thomas Knöpfel